SEC Form 4 · accession 0001534424-16-000683
ClearPoint Neuro, Inc. · CLPT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Wendelin C Maners
Officer — Vice President, Marketing
Period of report
Mar 30, 2016
Accepted (ET)
Apr 1, 2016 · 4:14 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001285550
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Options (right to buy)F1 | $0.31 | Mar 30, 2016 | A | 75,000 | A | — | Mar 30, 2026 | Common Stock | 75,000 | 75,000 | D |
Explanation of responses
- F1The shares subject to this option vest ratably in three equal installments on December 1, 2016, December 1, 2017 and December 1, 2018.